Clinical Trials Directory

Trials / Completed

CompletedNCT03872297

Fish Collagen Peptide Food Supplement on Weight and Body Composition

Effect of a Fish Collagen Peptide Food Supplement on the Weight and Body Composition of Healthy Volunteers in Overweight

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Institut Pasteur de Lille · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Fish collagen hydrolysates or peptides orally administered have been investigated in recent clinical trials in human health. These peptides have been evaluated in various biological and medical fields including skin aging, osteoarticular apparatus, muscle and more recently in energy metabolism in both animals and humans. However, very few studies investigated the effect of fish collagen peptides on weight, body composition or glycemic response. Recently, it has been shown that the consumption of fish collagen peptides (Naticol®) limits weight gain and increase in fat mass in a mouse model made obese by a hyperlipidic diet. Since these results have never been observed in humans, this pilot study proposes to answer this question.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo supplementConsumption of a non active food complement during 3 months. Tests performed : * 2 blood tests : * 2 body composition analysis via Dual-energy X-ray absorptiometry (DXA) * 2 stool collections The first one of these analysis was performed at the beginning, second at the end of the study.
DIETARY_SUPPLEMENTNaticol supplementConsumption of the active food complement during 3 months containing Naticol. Tests performed : * 2 blood tests : * 2 body composition analysis via Dual-energy X-ray absorptiometry (DXA) * 2 stool collections The first one of these analysis was performed at the beginning, second at the end of the study.

Timeline

Start date
2019-01-14
Primary completion
2019-06-30
Completion
2019-07-30
First posted
2019-03-13
Last updated
2022-12-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03872297. Inclusion in this directory is not an endorsement.